The iFuse Implant System® was developed as a minimally invasive surgical option for patients who have failed non-surgical treatment options. Since it was first introduced in 2009, tens of thousands of procedures have been performed by thousands of surgeons who have been specifically trained to provide this option for their patients.
The iFuse Implant System consists of cannulated triangular, titanium (Ti 6Al4V ELI) implants with a porous surface and an instrument system. Implant surface and shape are designed to prevent rotation and motion of the sacroiliac (SI) joint. The instrument system uses guide pins for accurate placement.
The iFuse Implant System is intended for sacroiliac fusion for the following conditions:
The iFuse-3D Implant, created with the latest 3D-printing technology, combines the patented triangular shape of the iFuse Implant with a proprietary 3D-printed porous trabecular surface and unique patented fenestrated design.
Designed to stabilize and fuse the SI joint, SI-BONE has developed a minimally invasive surgical (MIS), innovative, patented, sacroiliac implant system for sacroiliac (SI) joint conditions including disruption and degenerative sacroiliitis.
The iFuse Implant System® consists of titanium implants and associated surgical instruments.
The iFuse Implant, available since 2009, is made of titanium and has a porous, titanium plasma spray (TPS) coating. TPS technology has been used for decades in other medical applications such as orthopedics and dentistry. Peer-reviewed articles demonstrate safety and effectiveness of the iFuse Implant.
There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and not all patients may benefit. For full prescribing information, including indications, contraindications, risk and safety information, please click here.
Talk to an Orb Medical Specialist about sourcing the iFuse Implant System® for your patients.
Founder & CEO